Cypherpunk Technologies Inc. (CYPH) shareholders
Close on Nov 13, 2026Market cap $201.52MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Winklevoss Capital Fund, LLC Joint filing with Winklevoss Treasury Investments, LLC (19.90%), Winklevoss Capital Management, LLC (19.90%) and 2 more | 24,854,613 | 19.90% | 13D (active) amendment | Aug 17, 2026 |
| Winklevoss Capital Management, LLC Joint filing with Winklevoss Capital Fund, LLC (19.90%), Winklevoss Treasury Investments, LLC (19.90%) and 2 more | 12,084,463 | 19.90% | 13D (active) | Oct 8, 2025 |
| Winklevoss Treasury Investments, LLC Joint filing with Winklevoss Capital Fund, LLC (19.90%), Winklevoss Capital Management, LLC (19.90%) and 2 more | 12,084,463 | 19.90% | 13D (active) amendment | Oct 8, 2025 |
| Severns Sean Michael | 6,000,000 | 10.59% | 13G (passive) | Nov 12, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CYPH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 3,887,574 | 3.61% | $2.38M | +2,069,160 | 0.00% |
| BlackRock, Inc. | 2,622,823 | 2.43% | $1.61M | +280,649 | 0.00% |
| Jane Street Group, LLC | 1,701,926 | 1.58% | $1.04M | New | 0.00% |
| Geode Capital Management, LLC | 1,173,737 | 1.09% | $718.80K | +602,669 | 0.00% |
| UBS Group AG | 1,127,366 | 1.05% | $689.95K | +956,298 | 0.00% |
| Citadel Advisors LLC | 836,153 | 0.78% | $511.98K | New | 0.00% |
| XTX Topco Ltd | 638,329 | 0.59% | $390.85K | +607,671 | 0.01% |
| Vanguard Fiduciary Trust Co | 571,345 | 0.53% | $349.66K | +274,259 | 0.00% |
| State Street Corp | 516,113 | 0.48% | $316.02K | +376,000 | 0.00% |
| Northern Trust Corp | 222,031 | 0.21% | $135.95K | +134,469 | 0.00% |
| Susquehanna International Group, Llp | 217,997 | 0.20% | $133.48K | −44,956 | 0.00% |
| Morgan Stanley | 174,586 | 0.16% | $106.90K | +137,081 | 0.00% |
| LPL Financial LLC | 159,194 | 0.15% | $97.47K | −3,300 | 0.00% |
| Sequoia Financial Advisors, LLC | 152,500 | 0.14% | $93.38K | +104,500 | 0.00% |
| HighTower Advisors, LLC | 100,580 | 0.09% | $61.59K | +40,080 | 0.00% |
| Virtu Financial LLC | 86,789 | 0.08% | $53.00K | +76,601 | 0.00% |
| Two Sigma Investments, LP | 80,411 | 0.07% | $49.24K | +13,839 | 0.00% |
| Key Client Fiduciary Advisors, LLC | 75,102 | 0.07% | $45.99K | −5,322 | 0.01% |
| Farther Finance Advisors, LLC | 44,844 | 0.04% | $27.46K | +42,786 | 0.00% |
| Texas Capital Bank Wealth Management Services Inc | 37,600 | 0.03% | $23.02K | −66,600 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 47 | 15M | 13.6% | 13 / 16 | 6 / 5 | 8M | 1M |
| Q1 2026 | 40 | 7M | 6.8% | 12 / 5 | 8 / 9 | 3M | 3M |
| Q4 2025 | 38 | 9M | 8.0% | 13 / 13 | 7 / 8 | 6M | 10M |
| Q3 2025 | 33 | 13M | 11.8% | 2 / 8 | 7 / 12 | 2M | 3M |
| Q2 2025 | 43 | 14M | 12.8% | 6 / 10 | 12 / 8 | 1M | 4M |
| Q1 2025 | 45 | 17M | 15.5% | 11 / 9 | 14 / 23 | 2M | 5M |
| Q4 2024 | 57 | 19M | 17.8% | 15 / 20 | 9 / 6 | 8M | 4M |
| Q3 2024 | 48 | 15M | 13.8% | 11 / 9 | 12 / 8 | 1M | 1M |
| Q2 2024 | 46 | 15M | 13.7% | 8 / 18 | 9 / 6 | 7M | 1M |
| Q1 2024 | 44 | 8M | 7.9% | 11 / 12 | 9 / 9 | 3M | 1M |
| Q4 2023 | 43 | 7M | 6.4% | 9 / 14 | 10 / 8 | 1M | 2M |
| Q3 2023 | 42 | 8M | 7.2% | 10 / 13 | 7 / 5 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
11 funds held CYPH in Q2 2026, 87% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CYPH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,630,994 | 2.44% | $1.61M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,148,035 | 1.07% | $702.94K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 264,741 | 0.25% | $299.16K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 89,230 | 0.08% | $100.83K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 76,899 | 0.07% | $47.09K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 71,448 | 0.07% | $80.74K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 52,280 | 0.05% | $59.08K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 31,646 | 0.03% | $19.38K | 0.00% | Jun 30, 2026 |
| Simplify Health Care ETF | 27,979 | 0.03% | $17.13K | 0.00% | Jun 30, 2026 |
| Victory Extended Market Index Fund | 9,914 | 0.01% | $5.86K | 0.00% | Jul 31, 2026 |
| Total Stock Market Index Trust | 1,572 | 0.00% | $963 | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -2,100 | -0.00% | -$1.29K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William Patrick McEvoy III | Chief Investment Officer, Director, 10% owner | 29,793,414 | 27.65% | Oct 14, 2026 |
| Douglas E. Onsi | CEO,CFO,Pres.,GC,Treas.&Sec., Director | 106,858 | 0.10% | Jul 2, 2026 |
| Kevin Zhang | Head of Mining | 330,904 | 0.31% | Aug 24, 2026 |
| John Mark O'Mahony | Chief Manufacturing Officer | 27,500 | 0.03% | Jul 1, 2025 |
| Augustine Lawlor | Chief Operating Officer | 706,042 | 0.66% | Jul 1, 2025 |
| Jason Baum | Chief Scientific Officer | 15,896 | 0.01% | Jul 1, 2025 |
| Christine Granfield | VP, Head of Reg Affairs/Qual | 22,500 | 0.02% | Apr 1, 2025 |
| Cynthia Sirard | Chief Medical Officer | 27,500 | 0.03% | Apr 1, 2025 |
| Patricia A. Martin | Director | 118,750 | 0.11% | Sep 25, 2026 |
| Khing Djien Oei | Director | 0 | – | Sep 25, 2026 |
| Amanda Fabiano | Director | – | – | Sep 25, 2026 |
| Thomas John Dietz | Director | 132,500 | 0.12% | Aug 27, 2026 |
| Nissim Mashiach | Director | 168,750 | 0.16% | Jul 2, 2026 |
| William Li | Director | 74,700 | 0.07% | Jul 2, 2026 |
| Christian M. Richard | Director | 74,700 | 0.07% | Jul 2, 2026 |
| Christopher Mirabelli | Director | 130,376 | 0.12% | Mar 30, 2026 |
| Richard Schilsky | Director | 74,700 | 0.07% | Mar 17, 2026 |
| James H. Cavanaugh | Director | 168,963 | 0.16% | Mar 17, 2026 |
| Joseph Loscalzo | Director | 168,750 | 0.16% | Mar 17, 2026 |
| Tyler Howard Winklevoss | 10% owner | 24,854,613 | 23.06% | Oct 14, 2026 |
| Cameron Howard Winklevoss | 10% owner | – | – | Oct 14, 2026 |
| Winklevoss Treasury Investments, LLC | 10% owner | – | – | Oct 14, 2026 |
| Winklevoss Capital Fund, LLC | 10% owner | 29,793,414 | 27.65% | Oct 14, 2026 |
| Winklevoss Capital Management, LLC | 10% owner | 8,283,761 | 7.69% | Oct 14, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William Patrick McEvoy III Chief Investment Officer, Director, 10% owner | Oct 12, 2026 | Option exercise | +4,938,801 | $0.00 | $4.94K | 29,793,414 |
| Winklevoss Capital Fund, LLC 10% owner | Oct 12, 2026 | Option exercise | +4,938,801 | $0.00 | $4.94K | 29,793,414 |
| Khing Djien Oei Director | Sep 25, 2026 | Sale | −168,750 | $3.92 | $661.50K | 0 |
| Patricia A. Martin Director | Sep 23, 2026 | Sale | −50,000 | $3.86 | $193.00K | 118,750 |
| Thomas John Dietz Director | Aug 26, 2026 | Sale | −20,000 | $1.72 | $34.40K | 132,500 |
| William Patrick McEvoy III Chief Investment Officer, Director, 10% owner | Aug 17, 2026 | Option exercise | +16,570,852 | – | – | 24,854,613 |
| Tyler Howard Winklevoss 10% owner | Aug 17, 2026 | Option exercise | +16,570,852 | – | – | 24,854,613 |
| Christopher Mirabelli Director | Mar 26, 2026 | Sale | −60,000 | $0.71 | $42.60K | 130,376 |
| Nissim Mashiach Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| Nissim Mashiach Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| Khing Djien Oei Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| Khing Djien Oei Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| James H. Cavanaugh Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,963 |
| James H. Cavanaugh Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,913 |
| Patricia A. Martin Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| Patricia A. Martin Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| Christian M. Richard Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| Christian M. Richard Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| Richard Schilsky Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| Richard Schilsky Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| Christopher Mirabelli Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 190,376 |
| Christopher Mirabelli Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 96,326 |
| William Li Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| William Li Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| Thomas John Dietz Director | Mar 13, 2026 | Option exercise | +104,500 | – | – | 152,500 |
| Joseph Loscalzo Director | Mar 13, 2026 | Option exercise | +94,050 | – | – | 168,750 |
| Joseph Loscalzo Director | Mar 13, 2026 | Option exercise | +74,700 | – | – | 74,700 |
| Thomas John Dietz Director | Dec 26, 2025 | Option exercise | +83,000 | – | – | 83,000 |
| Thomas John Dietz Director | Dec 26, 2025 | Tax withholding | −35,000 | $1.20 | $42.00K | 48,000 |
| Christopher Mirabelli Director | Dec 23, 2025 | Other | +712 | – | – | 21,626 |
| Christopher Mirabelli Director | Dec 23, 2025 | Other | −2,136 | – | – | 0 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director | Dec 23, 2025 | Other | −2,136 | – | – | 0 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director | Dec 23, 2025 | Other | +712 | – | – | 106,858 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director | Nov 17, 2025 | Sale | −261,840 | $3.14 | $822.18K | 416,616 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director | Nov 17, 2025 | Sale | −414,479 | $3.14 | $1.30M | 2,136 |
| Christopher Mirabelli Director | Nov 17, 2025 | Sale | −261,840 | $3.14 | $822.18K | 416,616 |
| Christopher Mirabelli Director | Nov 17, 2025 | Sale | −414,479 | $3.14 | $1.30M | 2,136 |
| James H. Cavanaugh Director | Nov 17, 2025 | Sale | −261,840 | $3.14 | $822.18K | 0 |
| Augustine Lawlor Chief Operating Officer | Mar 28, 2025 | Option exercise | +22,500 | – | – | 27,586 |
| Augustine Lawlor Chief Operating Officer | Mar 28, 2025 | Tax withholding | −7,797 | $0.32 | $2.50K | 19,789 |
| Christine Granfield VP, Head of Reg Affairs/Qual | Mar 28, 2025 | Option exercise | +22,500 | – | – | 22,500 |
| Christine Granfield VP, Head of Reg Affairs/Qual | Mar 28, 2025 | Tax withholding | −6,604 | $0.32 | $2.11K | 15,896 |
| Cynthia Sirard Chief Medical Officer | Mar 28, 2025 | Option exercise | +22,500 | – | – | 27,500 |
| Christopher Mirabelli Chairman of the Board, Director | Mar 28, 2025 | Tax withholding | −6,672 | $0.32 | $2.14K | 20,914 |
| Christopher Mirabelli Chairman of the Board, Director | Mar 28, 2025 | Option exercise | +22,500 | – | – | 27,586 |
| Jason Baum Chief Scientific Officer | Mar 28, 2025 | Tax withholding | −6,604 | $0.32 | $2.11K | 15,896 |
| Jason Baum Chief Scientific Officer | Mar 28, 2025 | Option exercise | +22,500 | – | – | 22,500 |
| John Mark O'Mahony Chief Manufacturing Officer | Mar 28, 2025 | Option exercise | +22,500 | – | – | 27,500 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director | Mar 28, 2025 | Option exercise | +32,500 | – | – | 106,146 |
| Christopher Mirabelli Chairman of the Board, Director | Nov 13, 2024 | Option exercise | +2,136 | $2.82 | $6.02K | 678,456 |
| Augustine Lawlor Chief Operating Officer | Nov 13, 2024 | Option exercise | +2,136 | $2.82 | $6.02K | 678,456 |
| James H. Cavanaugh Director | Nov 13, 2024 | Option exercise | +213 | $2.82 | $601 | 213 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director | Nov 13, 2024 | Option exercise | +2,136 | $2.82 | $6.02K | 678,456 |
| John Mark O'Mahony Chief Manufacturing Officer | Jan 26, 2024 | Option exercise | +5,000 | – | – | 5,000 |
| Augustine Lawlor Chief Operating Officer | Jan 26, 2024 | Option exercise | +5,000 | – | – | 5,086 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Jan 26, 2024 | Option exercise | +7,500 | – | – | 73,646 |
| Cynthia Sirard Chief Medical Officer | Jan 26, 2024 | Option exercise | +5,000 | – | – | 5,000 |
| Christopher Mirabelli Chairman of the Board, Director | Jan 26, 2024 | Option exercise | +5,000 | – | – | 5,086 |
| Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.,&Sec., Director | Mar 17, 2023 | Option exercise | +660,606 | – | – | 661,466 |
| BeiGene, Ltd. 10% owner | Sep 24, 2021 | Buy | +2,543,800 | $2.85 | $7.25M | 7,348,437 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cypherpunk Technologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 225,144 shares on Oct 14, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Thomas John Dietz Director | Aug 26, 2026 | 20,000 | $32.30K | Aug 26, 2026 | Restricted Stock Unit |
| Christopher Mirabelli Director | Mar 27, 2026 | 60,000 | $42.63K | Mar 26, 2026 | RSU Settlement |
See a number that looks wrong?